At the ECCO 2025 Congress, researchers presented a study showing that machine learning can identify gut microbial biomarkers that differentiate IBD patients—particularly those with Crohn’s disease—from healthy individuals. The study analyzed stool samples from over 3,700 participants, finding that supervised machine learning had the highest diagnostic accuracy (AUC 0.971).
Trending
- Cylinder Health strengthens gut-brain leadership with new Head of Gut-Brain Health and Clinical Advisory Board appointment (Cylinder Health)
- The new era of physician independence (Medical Economics)
- “Don’t Take Shortcuts,” Endoscopy Researcher Advises (GI & Hepatology News)
- Olympus Unveils Corporate Strategy (Olympus)
- Unlocking value creation in healthcare: How AI can reverse private equity’s return challenges – Part 1: HealthTech and tech-enabled services (Lexology)
- 5 highest-paid gastroenterologists in New York City (Becker’s GI & Endoscopy)
- And Your 2025 Healio Disruptive Innovators Are … (Healio)
- The Hype and Limits of At-Home Gut Microbiome Tests (U.S. News)
